{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:24:48Z","timestamp":1767180288446,"version":"build-2238731810"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004571","name":"Minist\u00e8re des Affaires Sociales et de la Sant\u00e9","doi-asserted-by":"publisher","award":["Bourse ann\u00e9e recherche 2017\/2018"],"award-info":[{"award-number":["Bourse ann\u00e9e recherche 2017\/2018"]}],"id":[{"id":"10.13039\/501100004571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006390","name":"Universit\u00e9 de Lausanne","doi-asserted-by":"publisher","award":["doctoral research scholarship"],"award-info":[{"award-number":["doctoral research scholarship"]}],"id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lilly Company","award":["-"],"award-info":[{"award-number":["-"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0229145","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T13:42:58Z","timestamp":1582551778000},"page":"e0229145","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes"],"prefix":"10.1371","volume":"15","author":[{"given":"Anne-Caroline","family":"Jeannin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe-Elie","family":"Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziad","family":"Massy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8325-8784","authenticated-orcid":true,"given":"Carole Elodie","family":"Aubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cees","family":"Vemeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chlo\u00e9","family":"Amouyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franck","family":"Phan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marine","family":"Halbron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Funck-Brentano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agn\u00e8s","family":"Hartemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7348-7161","authenticated-orcid":true,"given":"Olivier","family":"Bourron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,2,24]]},"reference":[{"issue":"Suppl 1","key":"pone.0229145.ref001","first-page":"S124","article-title":"Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019","volume":"42","year":"2019","journal-title":"Diabetes Care"},{"issue":"11","key":"pone.0229145.ref002","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s001250051062","article-title":"Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4","volume":"41","author":"CM Forsblom","year":"1998","journal-title":"Diabetologia"},{"issue":"5","key":"pone.0229145.ref003","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2337\/diacare.13.5.513","article-title":"Pathways to diabetic limb amputation. Basis for prevention","volume":"13","author":"RE Pecoraro","year":"1990","journal-title":"Diabetes Care"},{"issue":"1\u20132","key":"pone.0229145.ref004","first-page":"48","article-title":"Risk Factors and Comorbidities in Diabetic Neuropathy: An Update 2015","volume":"12","author":"N Papanas","journal-title":"Rev Diabet Stud. 2015 Spring-Summer"},{"issue":"2","key":"pone.0229145.ref005","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.diabres.2015.04.031","article-title":"Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: A review of the literature","volume":"109","author":"CJ Alleman","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"pone.0229145.ref006","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.neuron.2017.02.005","article-title":"New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and","volume":"93","author":"EL Feldman","year":"2017","journal-title":"Pain. Neuron"},{"issue":"8","key":"pone.0229145.ref007","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/dmrr.2529","article-title":"Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes","volume":"30","author":"CE Aubert","year":"2014","journal-title":"Diabetes Metab Res Rev"},{"issue":"12","key":"pone.0229145.ref008","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1111\/j.1538-7836.2007.02758.x","article-title":"Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification","volume":"5","author":"LJ Schurgers","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"1","key":"pone.0229145.ref009","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0167-4838(91)90088-H","article-title":"Vitamin K-dependent carboxylase: utilization of decarboxylated bone Gla protein and matrix Gla protein as substrates","volume":"1078","author":"JA Engelke","year":"1991","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"pone.0229145.ref010","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/pro.5560030511","article-title":"Conserved phosphorylation of serines in the Ser-X-Glu\/Ser(P) sequences of the vitamin K-dependent matrix Gla protein from shark, lamb, rat, cow, and human","volume":"3","author":"PA Price","year":"1994","journal-title":"Protein Sci"},{"issue":"3","key":"pone.0229145.ref011","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0006-291X(83)91663-7","article-title":"Matrix Gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone","volume":"117","author":"PA Price","year":"1983","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"pone.0229145.ref012","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/glia.20531","article-title":"Glia-induced neuronal differentiation by transcriptional regulation","volume":"55","author":"C Goritz","year":"2007","journal-title":"Glia"},{"issue":"1","key":"pone.0229145.ref013","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ajmg.a.30680","article-title":"A novel MGP mutation in a consanguineous family: review of the clinical and molecular characteristics of Keutel syndrome","volume":"135","author":"DJ Hur","year":"2005","journal-title":"Am J Med Genet A"},{"issue":"6","key":"pone.0229145.ref014","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1538-7836.2011.04263.x","article-title":"Circulating matrix gamma-carboxyglutamate protein (MGP) species are refractory to vitamin K treatment in a new case of Keutel syndrome","volume":"9","author":"EC Cranenburg","year":"2011","journal-title":"J Thromb Haemost"},{"key":"pone.0229145.ref015","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/1471-2407-9-302","article-title":"Matrix gla protein (MGP): an overexpressed and migration-promoting mesenchymal component in glioblastoma","volume":"9","author":"S Mertsch","year":"2009","journal-title":"BMC Cancer"},{"issue":"3","key":"pone.0229145.ref016","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neulet.2009.11.002","article-title":"Differential gene expression analysis of human entorhinal cortex support a possible role of some extracellular matrix proteins in the onset of Alzheimer disease","volume":"468","author":"I Santa-Maria","year":"2010","journal-title":"Neurosci Lett"},{"issue":"11","key":"pone.0229145.ref017","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1210\/jc.2014-1047","article-title":"Below-knee arterial calcification in type 2 diabetes: association with receptor activator of nuclear factor kappaB ligand, osteoprotegerin, and neuropathy","volume":"99","author":"O Bourron","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"pone.0229145.ref018","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00400697","article-title":"A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population","volume":"36","author":"MJ Young","year":"1993","journal-title":"Diabetologia"},{"issue":"5","key":"pone.0229145.ref019","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1464-5491.2002.00698.x","article-title":"The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort","volume":"19","author":"CA Abbott","year":"2002","journal-title":"Diabet Med"},{"issue":"5","key":"pone.0229145.ref020","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2337\/diacare.10.5.613","article-title":"Influence of height on quantitative sensory, nerve-conduction, and clinical indices of diabetic peripheral neuropathy","volume":"10","author":"MT Gadia","year":"1987","journal-title":"Diabetes Care"},{"key":"pone.0229145.ref021","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3389\/fnins.2016.00581","article-title":"A Role for Insulin in Diabetic Neuropathy","volume":"10","author":"CW Grote","year":"2016","journal-title":"Front Neurosci"},{"issue":"6","key":"pone.0229145.ref022","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1074\/jbc.M109683200","article-title":"Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2","volume":"277","author":"AF Zebboudj","year":"2002","journal-title":"J Biol Chem"},{"issue":"2","key":"pone.0229145.ref023","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ydbio.2007.12.041","article-title":"Target-dependent inhibition of sympathetic neuron growth via modulation of a BMP signaling pathway","volume":"315","author":"JI Moon","year":"2008","journal-title":"Dev Biol"},{"issue":"38","key":"pone.0229145.ref024","doi-asserted-by":"crossref","first-page":"15132","DOI":"10.1523\/JNEUROSCI.4748-12.2013","article-title":"Dendrite complexity of sympathetic neurons is controlled during postnatal development by BMP signaling","volume":"33","author":"A Majdazari","year":"2013","journal-title":"J Neurosci"},{"issue":"1","key":"pone.0229145.ref025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000084531","article-title":"Inhibition of glial maturation by bone morphogenetic protein 2 in a neural crest-derived cell line","volume":"27","author":"JJ Dore","year":"2005","journal-title":"Dev Neurosci"},{"issue":"3","key":"pone.0229145.ref026","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bjoms.2006.06.003","article-title":"The role of bone morphogenetic protein-2 in vivo in regeneration of peripheral nerves","volume":"45","author":"YL Wang","year":"2007","journal-title":"Br J Oral Maxillofac Surg"},{"key":"pone.0229145.ref027","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/B978-0-12-410499-0.00010-1","article-title":"Extracellular matrix components in peripheral nerve regeneration","volume":"108","author":"F Gonzalez-Perez","year":"2013","journal-title":"Int Rev Neurobiol"},{"issue":"5","key":"pone.0229145.ref028","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.matbio.2005.05.004","article-title":"Matrix Gla protein C-terminal region binds to vitronectin. Co-localization suggests binding occurs during tissue development","volume":"24","author":"SK Nishimoto","year":"2005","journal-title":"Matrix Biol"},{"key":"pone.0229145.ref029","doi-asserted-by":"crossref","first-page":"807013","DOI":"10.1155\/2014\/807013","article-title":"Matrix gla protein binds to fibronectin and enhances cell attachment and spreading on fibronectin","volume":"2014","author":"SK Nishimoto","year":"2014","journal-title":"Int J Cell Biol"},{"issue":"4","key":"pone.0229145.ref030","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1160\/TH09-11-0786","article-title":"Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species","volume":"104","author":"EC Cranenburg","year":"2010","journal-title":"Thromb Haemost"},{"issue":"11","key":"pone.0229145.ref031","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.2337\/dc13-0065","article-title":"Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients","volume":"36","author":"GW Dalmeijer","year":"2013","journal-title":"Diabetes Care"},{"issue":"1","key":"pone.0229145.ref032","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0002-9343(80)90181-3","article-title":"Maternal and fetal sequelae of anticoagulation during pregnancy","volume":"68","author":"JG Hall","year":"1980","journal-title":"Am J Med"},{"issue":"8","key":"pone.0229145.ref033","doi-asserted-by":"crossref","first-page":"e0203057","DOI":"10.1371\/journal.pone.0203057","article-title":"Vitamin K enhances the production of brain sulfatides during remyelination","volume":"13","author":"DC Popescu","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"pone.0229145.ref034","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0092-8674(00)80093-8","article-title":"Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability","volume":"86","author":"T Coetzee","year":"1996","journal-title":"Cell"},{"issue":"1","key":"pone.0229145.ref035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0165-3806(93)90041-8","article-title":"Age-dependent survival-promoting activity of vitamin K on cultured CNS neurons","volume":"73","author":"M Nakajima","year":"1993","journal-title":"Brain Res Dev Brain Res"},{"issue":"5","key":"pone.0229145.ref036","first-page":"830","article-title":"[Type 2 diabetes in France: epidemiology, trends of medical care, social and economic burden","volume":"42","author":"C Druet","year":"2013","journal-title":"Presse Med"},{"key":"pone.0229145.ref037","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neulet.2014.11.020","article-title":"Toll-like receptor 4 and tumor necrosis factor-alpha as diagnostic biomarkers for diabetic peripheral neuropathy","volume":"585","author":"T Zhu","year":"2015","journal-title":"Neurosci Lett"},{"issue":"11","key":"pone.0229145.ref038","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.2337\/dc13-0590","article-title":"NSE, a potential biomarker, is closely connected to diabetic peripheral neuropathy","volume":"36","author":"J Li","year":"2013","journal-title":"Diabetes Care"},{"issue":"3","key":"pone.0229145.ref039","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030628","article-title":"Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review","volume":"20","author":"S Roumeliotis","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"9","key":"pone.0229145.ref040","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/ajh\/hpy079","article-title":"Circulating Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Kidney Dysfunction and Arterial Stiffness","volume":"31","author":"H Puzantian","year":"2018","journal-title":"Am J Hypertens"},{"issue":"3","key":"pone.0229145.ref041","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000443426","article-title":"Plasma Desphospho-Uncarboxylated Matrix Gla Protein as a Marker of Kidney Damage and Cardiovascular Risk in Advanced Stage of Chronic Kidney Disease","volume":"41","author":"I Kurnatowska","year":"2016","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"pone.0229145.ref042","doi-asserted-by":"crossref","first-page":"15088","DOI":"10.1038\/s41598-018-33257-6","article-title":"Inactive matrix Gla protein is a novel circulating biomarker predicting retinal arteriolar narrowing in humans","volume":"8","author":"FF Wei","year":"2018","journal-title":"Sci Rep"},{"issue":"4","key":"pone.0229145.ref043","first-page":"CD004572","article-title":"Aldose reductase inhibitors for the treatment of diabetic polyneuropathy","volume":"17","author":"C Chalk","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"pone.0229145.ref044","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.clinthera.2005.08.001","article-title":"Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial","volume":"27","author":"AI Vinik","year":"2005","journal-title":"Clin Ther"},{"issue":"1","key":"pone.0229145.ref045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.abb.2003.08.013","article-title":"Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts","volume":"419","author":"PJ Thornalley","year":"2003","journal-title":"Arch Biochem Biophys"},{"issue":"18","key":"pone.0229145.ref046","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1517\/14656566.2014.972935","article-title":"Efficacy of alpha-lipoic acid in diabetic neuropathy","volume":"15","author":"N Papanas","year":"2014","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"pone.0229145.ref047","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00774-008-0008-8","article-title":"Randomized controlled study on the prevention of osteoporotic fractures (OF study): a phase IV clinical study of 15-mg menatetrenone capsules","volume":"27","author":"T Inoue","year":"2009","journal-title":"J Bone Miner Metab"},{"issue":"6","key":"pone.0229145.ref048","doi-asserted-by":"crossref","first-page":"e000455","DOI":"10.1161\/JAHA.113.000455","article-title":"Intake of dietary phylloquinone and menaquinones and risk of stroke","volume":"2","author":"LE Vissers","year":"2013","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"pone.0229145.ref049","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mus.880110106","article-title":"Detection, characterization, and staging of polyneuropathy: assessed in diabetics","volume":"11","author":"PJ Dyck","year":"1988","journal-title":"Muscle Nerve"},{"issue":"4","key":"pone.0229145.ref050","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2337\/diacare.10.4.432","article-title":"Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy","volume":"10","author":"PJ Dyck","year":"1987","journal-title":"Diabetes Care"},{"issue":"6","key":"pone.0229145.ref051","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1212\/WNL.41.6.799","article-title":"The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests","volume":"41","author":"PJ Dyck","year":"1991","journal-title":"Neurology"},{"issue":"6","key":"pone.0229145.ref052","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1212\/WNL.42.6.1164","article-title":"The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity","volume":"42","author":"PJ Dyck","year":"1992","journal-title":"Neurology"},{"issue":"4","key":"pone.0229145.ref053","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/mus.1040","article-title":"Correlation between nerve conduction studies and clinical scores in diabetic neuropathy","volume":"24","author":"I Feki","year":"2001","journal-title":"Muscle Nerve"},{"issue":"9","key":"pone.0229145.ref054","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1210\/jc.2016-2030","article-title":"Endothelial Dysfunction as a Link Between Cardiovascular Risk Factors and Peripheral Neuropathy in Diabetes","volume":"101","author":"M Roustit","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"pone.0229145.ref055","doi-asserted-by":"crossref","first-page":"806","DOI":"10.2337\/diabetes.55.03.06.db05-1237","article-title":"Muscle weakness: a progressive late complication in diabetic distal symmetric polyneuropathy","volume":"55","author":"CS Andreassen","year":"2006","journal-title":"Diabetes"},{"issue":"1","key":"pone.0229145.ref056","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jdiacomp.2005.11.002","article-title":"Bedside neuropathy disability score compared to quantitative sensory testing for measurement of diabetic neuropathy in children, adolescents, and young adults with type 1 diabetes","volume":"21","author":"N Weintrob","year":"2007","journal-title":"J Diabetes Complications"},{"issue":"6","key":"pone.0229145.ref057","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ana.410080608","article-title":"Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry","volume":"8","author":"PJ Dyck","year":"1980","journal-title":"Ann Neurol"},{"issue":"4","key":"pone.0229145.ref058","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/brain\/108.4.861","article-title":"Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy","volume":"108","author":"PJ Dyck","year":"1985","journal-title":"Brain"},{"issue":"4","key":"pone.0229145.ref059","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1212\/WNL.43.4.817","article-title":"The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study","volume":"43","author":"PJ Dyck","year":"1993","journal-title":"Neurology"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0232996","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229145","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T13:44:02Z","timestamp":1582551842000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229145"}},"subtitle":[],"editor":[{"given":"Rudolf","family":"Kirchmair","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,2,24]]},"references-count":59,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0229145","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,24]]}}}